Bengu Gerceker Turk
Research Subjects
Bengu Gerceker Turk has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
- Ayda Acar
Ege University Medical Faculty, Department of Dermatology and Venereology, Izmir
6 shared publications - Ilgen Ertam
Department of Dermatology and Venereology Faculty of Medicine, Ege University Izmir Türkiye
6 shared publications Tugrul Dereli
5 shared publications- Banu Yaman
Department of Pathology, Ege University Faculty of Medicine, Izmir, Turkey
4 shared publications - Can Ceylan
Department of Dermatology, Faculty of Medicine, Ege University
4 shared publications - Ayris Ozturk
Department of Dermatology, Izmir City Hospital, İzmir, Turkey
3 shared publications
Latest Publications
- Open Access
- 17 June 2025
- Published by Springer Nature in Annals of Hematology
- Vol. 104 (7) , 3829-3836
Secondary neoplasms in mycosis fungoides: evaluating risk factors and phototherapy impact in a comparative study
Patients with mycosis fungoides (MF) are at an increased risk of developing secondary neoplasms. We conducted a comparative analysis between MF patients with and without secondary neoplasms and non-MF patients to assess secondary neoplasm occurrence and identify potential risk factors. We aimed to evaluate the prevalence of secondary neoplasms and investigate associated risk factors in MF patients. Demographic data, treatments, phototherapy details, neoplasm occurrence and detection time, and mortality rates were collected and retrospectively analyzed for 252 MF and 278 control patients. The prevalence of secondary neoplasms was significantly higher in the MF group (13.9%) compared to the control group (3.6%) ( p < 0.001). MF patients with neoplasms had a higher average age and older age at MF diagnosis ( p = 0.003 and 0.016, respectively). Phototherapy type showed no significant association with neoplasm presence. Elevated initial and final beta-2 microglobulin levels were observed in MF patients with neoplasms ( p = 0.002 and 0.005, respectively). MF patients have a higher risk of developing secondary neoplasms compared to controls. Risk increases with older age at MF diagnosis and elevated beta-2 microglobulin levels. Phototherapy was not associated with the development of secondary neoplasms in MF patients. MF patients with secondary neoplasms exhibit higher mortality rates, underscoring the importance of early detection and vigilant monitoring.
- 17 June 2025
- Published by Springer Nature in Annals of Hematology
- Vol. 104 (7) , 3829-3836
Open AccessSecondary neoplasms in mycosis fungoides: evaluating risk factors and phototherapy impact in a comparative study
Patients with mycosis fungoides (MF) are at an increased risk of developing secondary neoplasms. We conducted a comparative analysis between MF patients with and without secondary neoplasms and non-MF patients to assess secondary neoplasm occurrence and identify potential risk factors. We aimed to evaluate the prevalence of secondary neoplasms and investigate associated risk factors in MF patients. Demographic data, treatments, phototherapy details, neoplasm occurrence and detection time, and mortality rates were collected and retrospectively analyzed for 252 MF and 278 control patients. The prevalence of secondary neoplasms was significantly higher in the MF group (13.9%) compared to the control group (3.6%) ( p < 0.001). MF patients with neoplasms had a higher average age and older age at MF diagnosis ( p = 0.003 and 0.016, respectively). Phototherapy type showed no significant association with neoplasm presence. Elevated initial and final beta-2 microglobulin levels were observed in MF patients with neoplasms ( p = 0.002 and 0.005, respectively). MF patients have a higher risk of developing secondary neoplasms compared to controls. Risk increases with older age at MF diagnosis and elevated beta-2 microglobulin levels. Phototherapy was not associated with the development of secondary neoplasms in MF patients. MF patients with secondary neoplasms exhibit higher mortality rates, underscoring the importance of early detection and vigilant monitoring.
- Open Access
- 30 April 2025
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 15 (2) , 4883
Long-Term Outcomes of Surgical and Chemical Matricectomy for Ingrown Toenail Management: A Retrospective Study
Introduction: Matricectomy is an effective treatment method for ingrown toenails. Objective: We aimed to examine the outcomes of matricectomy procedures performed for ingrown toenails at a dermatology clinic, including patient characteristics, recurrence rates, post-operative complications, and patient satisfaction associated with these procedures. Methods: Records of patients who underwent surgical or chemical matricectomy for ingrown toenails in our dermatological surgery unit between 2009 and 2023 were retrospectively reviewed. Results: A total of 300 matricectomies in 164 patients were examined in the study. A chemical matricectomy was performed on 97.6% (160) of 164 patients, while 2.4% (4) of patients underwent surgical matricectomy alone and 20.7% (34) underwent both surgical and chemical matricectomy. There was no significant difference in healing times and prolonged pain between surgical, sodium hydroxide, and phenol matricectomy. No significant relationships were found between the development of side effects, presence of diabetes mellitus, previous nail procedures, and having surgical, phenol or sodium hydroxide matricectomy. The order of recurrence rates from lowest to highest was combined surgical and chemical, sodium hydroxide, and phenol matricectomy, but this difference was not significant. Conclusion: We found no significant differences in recurrence rates, side effects, or patient satisfaction among surgical, sodium hydroxide, and phenol matricectomy procedures.
- 30 April 2025
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 15 (2) , 4883
Open AccessLong-Term Outcomes of Surgical and Chemical Matricectomy for Ingrown Toenail Management: A Retrospective Study
Introduction: Matricectomy is an effective treatment method for ingrown toenails. Objective: We aimed to examine the outcomes of matricectomy procedures performed for ingrown toenails at a dermatology clinic, including patient characteristics, recurrence rates, post-operative complications, and patient satisfaction associated with these procedures. Methods: Records of patients who underwent surgical or chemical matricectomy for ingrown toenails in our dermatological surgery unit between 2009 and 2023 were retrospectively reviewed. Results: A total of 300 matricectomies in 164 patients were examined in the study. A chemical matricectomy was performed on 97.6% (160) of 164 patients, while 2.4% (4) of patients underwent surgical matricectomy alone and 20.7% (34) underwent both surgical and chemical matricectomy. There was no significant difference in healing times and prolonged pain between surgical, sodium hydroxide, and phenol matricectomy. No significant relationships were found between the development of side effects, presence of diabetes mellitus, previous nail procedures, and having surgical, phenol or sodium hydroxide matricectomy. The order of recurrence rates from lowest to highest was combined surgical and chemical, sodium hydroxide, and phenol matricectomy, but this difference was not significant. Conclusion: We found no significant differences in recurrence rates, side effects, or patient satisfaction among surgical, sodium hydroxide, and phenol matricectomy procedures.
- Open Access
- 30 April 2025
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 15 (2) , 4883
Long-Term Outcomes of Surgical and Chemical Matricectomy for Ingrown Toenail Management: A Retrospective Study
Introduction: Matricectomy is an effective treatment method for ingrown toenails. Objective: We aimed to examine the outcomes of matricectomy procedures performed for ingrown toenails at a dermatology clinic, including patient characteristics, recurrence rates, post-operative complications, and patient satisfaction associated with these procedures. Methods: Records of patients who underwent surgical or chemical matricectomy for ingrown toenails in our dermatological surgery unit between 2009 and 2023 were retrospectively reviewed. Results: A total of 300 matricectomies in 164 patients were examined in the study. A chemical matricectomy was performed on 97.6% (160) of 164 patients, while 2.4% (4) of patients underwent surgical matricectomy alone and 20.7% (34) underwent both surgical and chemical matricectomy. There was no significant difference in healing times and prolonged pain between surgical, sodium hydroxide, and phenol matricectomy. No significant relationships were found between the development of side effects, presence of diabetes mellitus, previous nail procedures, and having surgical, phenol or sodium hydroxide matricectomy. The order of recurrence rates from lowest to highest was combined surgical and chemical, sodium hydroxide, and phenol matricectomy, but this difference was not significant. Conclusion: We found no significant differences in recurrence rates, side effects, or patient satisfaction among surgical, sodium hydroxide, and phenol matricectomy procedures.
- 30 April 2025
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 15 (2) , 4883
Open AccessLong-Term Outcomes of Surgical and Chemical Matricectomy for Ingrown Toenail Management: A Retrospective Study
Introduction: Matricectomy is an effective treatment method for ingrown toenails. Objective: We aimed to examine the outcomes of matricectomy procedures performed for ingrown toenails at a dermatology clinic, including patient characteristics, recurrence rates, post-operative complications, and patient satisfaction associated with these procedures. Methods: Records of patients who underwent surgical or chemical matricectomy for ingrown toenails in our dermatological surgery unit between 2009 and 2023 were retrospectively reviewed. Results: A total of 300 matricectomies in 164 patients were examined in the study. A chemical matricectomy was performed on 97.6% (160) of 164 patients, while 2.4% (4) of patients underwent surgical matricectomy alone and 20.7% (34) underwent both surgical and chemical matricectomy. There was no significant difference in healing times and prolonged pain between surgical, sodium hydroxide, and phenol matricectomy. No significant relationships were found between the development of side effects, presence of diabetes mellitus, previous nail procedures, and having surgical, phenol or sodium hydroxide matricectomy. The order of recurrence rates from lowest to highest was combined surgical and chemical, sodium hydroxide, and phenol matricectomy, but this difference was not significant. Conclusion: We found no significant differences in recurrence rates, side effects, or patient satisfaction among surgical, sodium hydroxide, and phenol matricectomy procedures.
- 13 September 2021
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 60 (3) , 299-301
Dövme alanında molluskum kontagiozum
Dövme birçok dermatolojik probleme yol açabilmektedir. Bu problemler, güneşe hassasiyet, dövme pigmentine karşı alerji, Hepatit B, C ve İmmun Bağışıklık Yetmezliği Virüs (HIV) enfeksiyonları dışında diğer birçok viral ve bakteriyel enfeksiyonlardır. On yedi yaşında erkek hasta altı hafta önce başlayan, sağ ön kolda dövme alanında kabartılar nedeniyle başvurdu. Hastanın öyküsünden dört ay önce sağ ön koluna dövme yaptırdığı öğrenildi. Dermatolojik muayenede sağ ön kol dövme alanına sınırlı, umbilike, 1-2 mm boyutunda papüller izlenmekteydi. Özgeçmiş ve soy geçmişinde herhangi bir özellik bulunmamaktaydı. Histopatolojik incelemede viral inklüzyon cisimcikleri izlendi. Klinik ve histopatolojik bulgularla hastaya molluskum kontagiozum tanısı kondu.
- 13 September 2021
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 60 (3) , 299-301
Dövme alanında molluskum kontagiozum
Dövme birçok dermatolojik probleme yol açabilmektedir. Bu problemler, güneşe hassasiyet, dövme pigmentine karşı alerji, Hepatit B, C ve İmmun Bağışıklık Yetmezliği Virüs (HIV) enfeksiyonları dışında diğer birçok viral ve bakteriyel enfeksiyonlardır. On yedi yaşında erkek hasta altı hafta önce başlayan, sağ ön kolda dövme alanında kabartılar nedeniyle başvurdu. Hastanın öyküsünden dört ay önce sağ ön koluna dövme yaptırdığı öğrenildi. Dermatolojik muayenede sağ ön kol dövme alanına sınırlı, umbilike, 1-2 mm boyutunda papüller izlenmekteydi. Özgeçmiş ve soy geçmişinde herhangi bir özellik bulunmamaktaydı. Histopatolojik incelemede viral inklüzyon cisimcikleri izlendi. Klinik ve histopatolojik bulgularla hastaya molluskum kontagiozum tanısı kondu.
- Open Access
- 26 October 2020
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- p. 97-108
Ege Üniversitesi Hastanesinde görülen melanom dışı deri kanserlerinin epidemiyolojik ve demografik özellikleri
Amaç: Bu çalışmada Ege Üniversitesi Hastanesi veri tabanındaki 1992-2017 yılları arası melanom dışı malign deri kanseri tanısı alan hastaların epidemiyolojik ve demografik özelliklerinin değerlendirilmesi amaçlanmıştır. Gereç ve Yöntem: Ege Üniversitesi Kanserle Savaş Araştırma ve Uygulama Merkezinin özel eğitimli ve sertifikalı kanser kayıt elemanları tarafından CANREG 4 programı ile kaydedilen 1992-2017 yılları arasında Ege Üniversitesinde kayıtlı 8395 melanom dışı malign deri kanseri tanılı hastanın; tanı yaşı, cinsiyeti, tümörün histopatolojik tanısı, tümör yerleşim yeri, hastalık evresi ve uygulanan tedavi yöntemleri değerlendirilmiştir. Kategorik değişkenler arası ilişki varlığı Ki-Kare yöntemiyle değerlendirilirken, gruplar arası nümerik değişkenler Kruskal Wallis ve Dunn Testi ile karşılaştırıldı. Tüm Hipotez testleri 0,05 önem seviyesinde uygulandı. Bulgular: Ege Üniversitesi Kanser Araştırma Merkezinde 1992 ile 2017 yılları arasında kayıtlı melanom dışı deri kanseri olan 8395 hastanın 8386’sı dahil edildi. Hastaların %55,9’unda bazal hücreli karsinom, %30,3’ünde skuamoz hücreli karsinom, %3,6’sında malign kutanöz yumuşak doku tümörü, %3,4’ünde bazoskuamoz karsinom, %2,7’sinde kutanöz lenfoma, %1,4’ünde malign deri eki tümörü, %0,4’ünde Merkel hücreli karsinom, %2,3’ünde sınıflandırılamayan tümör mevcuttu. Hastaların %57,3’ü erkek, %42,7’si kadındı. Yaş ortalaması 63,3±14,3 idi. Sonuçlar: Olguların çoğunu epitelyal karsinomlar oluşturmakta idi. Çalışmada en sık görülen kanser tipi bazal hücreli karsinomdu ve bunu ikinci sırada skuamoz hücreli karsinom izlemekteydi. En az görülen Merkel hücreli karsinomdu. Merkel hücreli karsinom dışında erkek cinsiyet daha baskındı. Yaş ortalaması en genç olan grup kutanöz lenfomalarken, en ileri yaş gruplu tümör skuamoz hücreli karsinomdu.
- 26 October 2020
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- p. 97-108
Open AccessEge Üniversitesi Hastanesinde görülen melanom dışı deri kanserlerinin epidemiyolojik ve demografik özellikleri
Amaç: Bu çalışmada Ege Üniversitesi Hastanesi veri tabanındaki 1992-2017 yılları arası melanom dışı malign deri kanseri tanısı alan hastaların epidemiyolojik ve demografik özelliklerinin değerlendirilmesi amaçlanmıştır. Gereç ve Yöntem: Ege Üniversitesi Kanserle Savaş Araştırma ve Uygulama Merkezinin özel eğitimli ve sertifikalı kanser kayıt elemanları tarafından CANREG 4 programı ile kaydedilen 1992-2017 yılları arasında Ege Üniversitesinde kayıtlı 8395 melanom dışı malign deri kanseri tanılı hastanın; tanı yaşı, cinsiyeti, tümörün histopatolojik tanısı, tümör yerleşim yeri, hastalık evresi ve uygulanan tedavi yöntemleri değerlendirilmiştir. Kategorik değişkenler arası ilişki varlığı Ki-Kare yöntemiyle değerlendirilirken, gruplar arası nümerik değişkenler Kruskal Wallis ve Dunn Testi ile karşılaştırıldı. Tüm Hipotez testleri 0,05 önem seviyesinde uygulandı. Bulgular: Ege Üniversitesi Kanser Araştırma Merkezinde 1992 ile 2017 yılları arasında kayıtlı melanom dışı deri kanseri olan 8395 hastanın 8386’sı dahil edildi. Hastaların %55,9’unda bazal hücreli karsinom, %30,3’ünde skuamoz hücreli karsinom, %3,6’sında malign kutanöz yumuşak doku tümörü, %3,4’ünde bazoskuamoz karsinom, %2,7’sinde kutanöz lenfoma, %1,4’ünde malign deri eki tümörü, %0,4’ünde Merkel hücreli karsinom, %2,3’ünde sınıflandırılamayan tümör mevcuttu. Hastaların %57,3’ü erkek, %42,7’si kadındı. Yaş ortalaması 63,3±14,3 idi. Sonuçlar: Olguların çoğunu epitelyal karsinomlar oluşturmakta idi. Çalışmada en sık görülen kanser tipi bazal hücreli karsinomdu ve bunu ikinci sırada skuamoz hücreli karsinom izlemekteydi. En az görülen Merkel hücreli karsinomdu. Merkel hücreli karsinom dışında erkek cinsiyet daha baskındı. Yaş ortalaması en genç olan grup kutanöz lenfomalarken, en ileri yaş gruplu tümör skuamoz hücreli karsinomdu.
Oral mukozada ve yüzde unilateral fibrolipomlar
Fibrolipoma is a rare, benign mesencyhmal tumour composed of mature adipose and mature collagenous fibrous tissue which is histologically classified as a variant of lipoma. Fibrolipomas may develop as solitary lesions anywhere on the body. However, involvement of the mucosal sites including the oral cavity, parotid gland, oesophagus and intestine is rare. In the oral mucosa, it is usually observed as a nodular, smooth surfaced, pedunculated or sessile mass. Here, we report unilateral multiple fibrolipomas on the right side of the face together with the ipsilateral oral mucosal involvement in a 46 year-old male patient.
Oral mukozada ve yüzde unilateral fibrolipomlar
Fibrolipoma is a rare, benign mesencyhmal tumour composed of mature adipose and mature collagenous fibrous tissue which is histologically classified as a variant of lipoma. Fibrolipomas may develop as solitary lesions anywhere on the body. However, involvement of the mucosal sites including the oral cavity, parotid gland, oesophagus and intestine is rare. In the oral mucosa, it is usually observed as a nodular, smooth surfaced, pedunculated or sessile mass. Here, we report unilateral multiple fibrolipomas on the right side of the face together with the ipsilateral oral mucosal involvement in a 46 year-old male patient.
- 4 September 2020
- Published by Galenos Yayinevi in Turkish Journal of Parasitology
- Vol. 44 (3) , 164-167
Comparison of Skin Scraping and Standard Superficial Skin Biopsy in the Laboratory Diagnosis of Scabies
Scabies is diagnosed based on the presence of burrows on the skin, Sarcoptes scabiei adult, egg, or scybala in skin scrapings. The laboratory diagnosis of scabies poses various challenges. We aimed to compare the analytical performance of skin scraping and standard superficial skin biopsy (SSSB) and to investigate the correlation with false negative results in the laboratory diagnosis of scabies. Skin scraping and SSSB were applied from July 1 to December 31, 2018 on 42 patients whose burrows were marked using dermatoscopy, as obtained from the laboratory information system. The number of patients who tested positive for scabies with skin scraping was 18 (42.9%) and 24 (57.1%) with SSSB, and the difference was significant (p=0.003). Sensitivity was 42.9% for skin scraping and 57.1% for SSSB. The number of positive cases with both techniques was 15 (35.7%). The number of patients positive with only skin scraping was 3 (7.1%) and only SSSB was 9 (21.4%). To date, it has seemed impossible to diagnose scabies using a single clinical or laboratory test. According to our results, SSSB is an inexpensive and easy-to-apply method with high sensitivity for obtaining skin samples for scabies laboratory diagnosis.
- 4 September 2020
- Published by Galenos Yayinevi in Turkish Journal of Parasitology
- Vol. 44 (3) , 164-167
Comparison of Skin Scraping and Standard Superficial Skin Biopsy in the Laboratory Diagnosis of Scabies
Scabies is diagnosed based on the presence of burrows on the skin, Sarcoptes scabiei adult, egg, or scybala in skin scrapings. The laboratory diagnosis of scabies poses various challenges. We aimed to compare the analytical performance of skin scraping and standard superficial skin biopsy (SSSB) and to investigate the correlation with false negative results in the laboratory diagnosis of scabies. Skin scraping and SSSB were applied from July 1 to December 31, 2018 on 42 patients whose burrows were marked using dermatoscopy, as obtained from the laboratory information system. The number of patients who tested positive for scabies with skin scraping was 18 (42.9%) and 24 (57.1%) with SSSB, and the difference was significant (p=0.003). Sensitivity was 42.9% for skin scraping and 57.1% for SSSB. The number of positive cases with both techniques was 15 (35.7%). The number of patients positive with only skin scraping was 3 (7.1%) and only SSSB was 9 (21.4%). To date, it has seemed impossible to diagnose scabies using a single clinical or laboratory test. According to our results, SSSB is an inexpensive and easy-to-apply method with high sensitivity for obtaining skin samples for scabies laboratory diagnosis.
- 2 July 2020
- Published by Taylor & Francis in Cutaneous and Ocular Toxicology
- Vol. 39 (3) , 249-253
Experience with Omalizumab for the treatment of chronic spontaneous urticaria in a tertiary center: real life experience
Purpose: Chronic spontaneous urticaria (CSU) is defined as urticaria and/or angioedema that appears spontaneously due to known or unknown causes and lasts for at least 6 weeks. Omalizumab, an anti-IgE antibody that binds circulating free IgE, has recently emerged as a promising treatment for CSU, a condition which impairs patients’ quality of life. We aimed to contribute real life data by reporting our experience with omalizumab in the treatment of intractable CSU. Methods: Of 140 patients treated with omalizumab in our clinic between September 2013 and January 2018, 86 CSU patients with available current data were retrospectively evaluated in terms of sex, age, urticaria duration, urticaria activity score over 7 days (UAS7) before and after omalizumab, relapses and time to relapse, length of remission after omalizumab cessation, adverse events, and comorbidities. Results: The mean age of the patients was 45.5 ± 14.3 years and 73.3% were women. Mean duration of urticaria before initiation of omalizumab therapy was 54.5 ± 67 months. All patients had used antihistamines before starting omalizumab treatment. The mean number of omalizumab doses was 11.9 ± 9.3. The mean duration of omalizumab treatment was 13.3 ± 10.4 months. Mean UAS7 score was 38.9 ± 4.1 before the start of omalizumab treatment, and 7.9 ± 10.5 after treatment. Treatment was discontinued in 10 patients (11.6%) due to nonresponse or loss of effect. Four patients (4.65%) experienced adverse events. Treatment was discontinued in 1 patient (1.16%) due to side effects. Of the 55 patients whose treatment was discontinued after their symptoms resolved, 31 (56.3%) relapsed after omalizumab cessation. Twenty-four patients (43.6%) did not relapse after omalizumab cessation. Conclusions: Our results show that omalizumab was an effective treatment for intractable CSU and did not cause any serious adverse effects other than asthenia, vertigo, and injection site reaction in 4 patients. These findings are relevant because they reflect real-life data.
- 2 July 2020
- Published by Taylor & Francis in Cutaneous and Ocular Toxicology
- Vol. 39 (3) , 249-253
Experience with Omalizumab for the treatment of chronic spontaneous urticaria in a tertiary center: real life experience
Purpose: Chronic spontaneous urticaria (CSU) is defined as urticaria and/or angioedema that appears spontaneously due to known or unknown causes and lasts for at least 6 weeks. Omalizumab, an anti-IgE antibody that binds circulating free IgE, has recently emerged as a promising treatment for CSU, a condition which impairs patients’ quality of life. We aimed to contribute real life data by reporting our experience with omalizumab in the treatment of intractable CSU. Methods: Of 140 patients treated with omalizumab in our clinic between September 2013 and January 2018, 86 CSU patients with available current data were retrospectively evaluated in terms of sex, age, urticaria duration, urticaria activity score over 7 days (UAS7) before and after omalizumab, relapses and time to relapse, length of remission after omalizumab cessation, adverse events, and comorbidities. Results: The mean age of the patients was 45.5 ± 14.3 years and 73.3% were women. Mean duration of urticaria before initiation of omalizumab therapy was 54.5 ± 67 months. All patients had used antihistamines before starting omalizumab treatment. The mean number of omalizumab doses was 11.9 ± 9.3. The mean duration of omalizumab treatment was 13.3 ± 10.4 months. Mean UAS7 score was 38.9 ± 4.1 before the start of omalizumab treatment, and 7.9 ± 10.5 after treatment. Treatment was discontinued in 10 patients (11.6%) due to nonresponse or loss of effect. Four patients (4.65%) experienced adverse events. Treatment was discontinued in 1 patient (1.16%) due to side effects. Of the 55 patients whose treatment was discontinued after their symptoms resolved, 31 (56.3%) relapsed after omalizumab cessation. Twenty-four patients (43.6%) did not relapse after omalizumab cessation. Conclusions: Our results show that omalizumab was an effective treatment for intractable CSU and did not cause any serious adverse effects other than asthenia, vertigo, and injection site reaction in 4 patients. These findings are relevant because they reflect real-life data.
- Open Access
Deri bulguları ile ortaya çıkan bir Staphylococcus aureus endokarditi
A Staphylococcus aureus endocarditis presented with skin findings www.mucosa.org Dear editor, A 46-year-old, previously healthy woman presented with a 20-day history of pain and discoloration of right index finger, fatigue, headache, and abdominal pain. Patient was hospitalized in a different clinic 10 days ago and a right brachial angiogram performed, showing distal occlusion of right index finger digital artery. Her medical history was unremarkable and did not include intravenous drug use, recent dental procedures, heart murmurs or cardiac abnormalities. On admission she was normotensive, with no fever and mild tachycardia (110 beats/min). Physical examination revealed an area of necrosis clearly visible at the distal phalanx of right index finger, multiple painful erythematous nodules, petechiae, purpura on the palmar surface of hands and feet, splinter hemorrhage, and painful nodular lesions on feet (Fig.1). Neurological and pulmonary examinations were normal. A systolic murmur heard at apical region on cardiac auscultation. Laboratory tests showed leukocytosis (16300/ mm 3), increased levels of C-reactive protein (7.59 mg/ dl) and elevated creatinine levels (2.25 mg/dl). Tests for human immunodeficiency virus, rheumatoid factor, and hepatitis were negative. Transthorasic echocardiogram detected the presence of a mobile mass 1
Open AccessDeri bulguları ile ortaya çıkan bir Staphylococcus aureus endokarditi
A Staphylococcus aureus endocarditis presented with skin findings www.mucosa.org Dear editor, A 46-year-old, previously healthy woman presented with a 20-day history of pain and discoloration of right index finger, fatigue, headache, and abdominal pain. Patient was hospitalized in a different clinic 10 days ago and a right brachial angiogram performed, showing distal occlusion of right index finger digital artery. Her medical history was unremarkable and did not include intravenous drug use, recent dental procedures, heart murmurs or cardiac abnormalities. On admission she was normotensive, with no fever and mild tachycardia (110 beats/min). Physical examination revealed an area of necrosis clearly visible at the distal phalanx of right index finger, multiple painful erythematous nodules, petechiae, purpura on the palmar surface of hands and feet, splinter hemorrhage, and painful nodular lesions on feet (Fig.1). Neurological and pulmonary examinations were normal. A systolic murmur heard at apical region on cardiac auscultation. Laboratory tests showed leukocytosis (16300/ mm 3), increased levels of C-reactive protein (7.59 mg/ dl) and elevated creatinine levels (2.25 mg/dl). Tests for human immunodeficiency virus, rheumatoid factor, and hepatitis were negative. Transthorasic echocardiogram detected the presence of a mobile mass 1
Toluidine blue application to detect dysplasia and malignant changes in patients with oral lichenoid lesions
Background Oral lichen planus (OLP) is a chronic disease with immune-mediated pathogenesis which can be premalignant. Oral lichenoid dysplasia (OLD) is a precancerous process with lichenoid features which is frequently confused with OLP.Objective In this study, we aimed to investigate the efficacy of toluidine blue (TB) administration before biopsy to detect the dysplastic changes in patients who were clinically diagnosed with OLP.Methods Thirty consecutive patients with oral lichenoid lesions whose clinical findings were consistent with OLP were included in the study. Demographic and clinical characteristics of the patients studied were recorded and clinical photos were taken before and after the administration of TB. Areas to be biopsied were determined according to the results of the TB staining. Histopathologically, all the specimens were evaluated in terms of the diagnostic features of OLP and the presence of dysplastic findings. Results The mean age of the 30 patients (21 females, 9 males) included in the study was 51.03 (26-70 years) and the median value of disease duration was 12.00 ± 67.23 months (2-360 months). Six patients (20.0%) had positive staining after application of TB. Histopathological examination revealed OLP findings in 17 patients (56.7%), OLP and dysplasia findings in nine patients (30.0%) and lichenoid dysplasia in four patients (13.3%). Dysplasia was detected in all of the lesions (six patients) which were stained blue with TB. The relationship between staining and dysplasia was significant (p<0.05). OLP and dysplasia were observed in four of these six patients (66.7%), and lichenoid dysplasia was observed in the other two (33.3%). The relationship between presence of dysplasia and presence of mitosis was found statistically significant in patients with histopathological dysplasia (p<0.05). When the presence of mitosis was evaluated in biopsies taken from the stained lesions, a statistically significant relation was found (p<0.05).ConclusionsIn our study, it was observed that dysplasia was detected in all stained areas after the application of TB to clinically classical OLP patients, but there was no staining in some patients despite the presence of dysplasia. Therefore, the sensitivity of the application was 46%, specificity was 100%, positive predictive value was 100% and negative predictive value was 70.8%. TB application is a specific test to detect the dysplasia; however because of the low sensitivity in oral lichenoid lesions, another method is needed to increase the sensitivity.
Toluidine blue application to detect dysplasia and malignant changes in patients with oral lichenoid lesions
Background Oral lichen planus (OLP) is a chronic disease with immune-mediated pathogenesis which can be premalignant. Oral lichenoid dysplasia (OLD) is a precancerous process with lichenoid features which is frequently confused with OLP.Objective In this study, we aimed to investigate the efficacy of toluidine blue (TB) administration before biopsy to detect the dysplastic changes in patients who were clinically diagnosed with OLP.Methods Thirty consecutive patients with oral lichenoid lesions whose clinical findings were consistent with OLP were included in the study. Demographic and clinical characteristics of the patients studied were recorded and clinical photos were taken before and after the administration of TB. Areas to be biopsied were determined according to the results of the TB staining. Histopathologically, all the specimens were evaluated in terms of the diagnostic features of OLP and the presence of dysplastic findings. Results The mean age of the 30 patients (21 females, 9 males) included in the study was 51.03 (26-70 years) and the median value of disease duration was 12.00 ± 67.23 months (2-360 months). Six patients (20.0%) had positive staining after application of TB. Histopathological examination revealed OLP findings in 17 patients (56.7%), OLP and dysplasia findings in nine patients (30.0%) and lichenoid dysplasia in four patients (13.3%). Dysplasia was detected in all of the lesions (six patients) which were stained blue with TB. The relationship between staining and dysplasia was significant (p<0.05). OLP and dysplasia were observed in four of these six patients (66.7%), and lichenoid dysplasia was observed in the other two (33.3%). The relationship between presence of dysplasia and presence of mitosis was found statistically significant in patients with histopathological dysplasia (p<0.05). When the presence of mitosis was evaluated in biopsies taken from the stained lesions, a statistically significant relation was found (p<0.05).ConclusionsIn our study, it was observed that dysplasia was detected in all stained areas after the application of TB to clinically classical OLP patients, but there was no staining in some patients despite the presence of dysplasia. Therefore, the sensitivity of the application was 46%, specificity was 100%, positive predictive value was 100% and negative predictive value was 70.8%. TB application is a specific test to detect the dysplasia; however because of the low sensitivity in oral lichenoid lesions, another method is needed to increase the sensitivity.